News

COMPLETION OF MERGER WITH THE WHOLLY OWNED SUBSIDIARY GENPOINT AS

NORDIAG RECEIVES NOK 3 MILLION IN LOAN FROM INNOVATION NORWAY - FOR AUTOMATION OF PRODUCTION LINE

MANDATORY NOTIFICATION OF TRADE

1H/Q2-2010 - STRONG MOMENTUM FOR THE ARROW INSTRUMENT CONFIRMS UNIQUENESS

INVITATION TO PRESENTATION OF SECOND QUARTER AND FIRST HALF OF 2010 FINANCIALS

SHARE CAPITAL INCREASE REGISTERED

OEM AGREEMENT SIGNED WITH SEEGENE INC., KOREA

NORDIAG CE IVD LABELS ITS ARROW VIRAL KIT

MANDATORY NOTIFICATION

MANDATORY NOTIFICATION OF TRADE

NORDIAG & MOLZYM LAUNCH ULTRA SENSITIVE PATHOGEN DETECTION SYSTEM

NORDIAG CE IVD LABELS ITS BULLET BLOOD KIT

COMMENCEMENT OF LAST POSSIBLE EXERCISE PERIOD FOR CLASS B WARRANTS

DISTRIBUTION AGREEMENT IN THE UNITED STATES WITH FISHER HEALTHCARE

WHOLLY OWNED SUBSIDIARY GENPOINT MERGES WITH PARENT COMPANY

MANDATORY NOTIFICATION OF TRADE

Q1-2010: STRONG PROGRESS FOR THE ARROW INSTRUMENT - OUTLOOK REMAINS SOLID

SHARE OPTION ALLOTMENT APPROVED

INVITATION TO PRESENTATION OF THE FIRST QUARTER 2010

Pages